Current solutions developed for the purpose of in and on body (IOB) electrical stimulation
(ES) lack autonomous qualities necessary for comfortable, practical, and self‐dependent …

Myocardial infarction is a prevalent major cardiovascular event that arises from myocardial
ischemia with or without reperfusion, and basic and translational research is needed to …

Heart failure is a global problem with an estimated prevalence of 38 million patients
worldwide, a number that is increasing with the ageing of the population. It is the most …

Implantation of bone-marrow stem cells in the heart might be a new method to restore tissue
viability after myocardial infarction. We injected up to 1.5× 10 6 autologous AC133+ bone …

M. Zhang, D. Methot, V. Poppa, Y. Fujio, K. Walsh and CE Murry. Cardiomyocyte Grafting for
Cardiac Repair: Graft Cell Death and Anti-Death Strategies. Journal of Molecular and …

Background—Autologous bone marrow cells (BMCs) transplanted into ventricular scar
tissue may differentiate into cardiomyocytes and restore myocardial function. This study …

Cell replacement therapy is a promising approach for the treatment of cardiac diseases, but
is challenged by a limited supply of appropriate cells. We have investigated whether …

Objectives: In this study, we determined whether fibrin glue improves cell transplant
retention and survival, reduces infarct expansion, and induces neovasculature formation …

Background—Promoting survival of transplanted cells or endogenous precursors is an
important goal. We hypothesized that a novel approach to promote vascularization would be …

Background—The myocardium is unable to regenerate because cardiomyocytes cannot
replicate after injury. The heart is therefore an attractive target for tissue engineering to …